Paper39871069
Kurarinone Mitigates LPS-Induced Inflammatory Osteolysis by Inhibiting Osteoclastogenesis Through the Reduction of ROS Levels and Suppression of the PI3K/AKT Signaling Pathway.
Lv H and 8 others. Inflammation, 2025. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. Kurarinone Mitigates LPS-Induced Inflammatory Osteolysis by Inhibiting Osteoclastogenesis Through the Reduction of ROS Levels and Suppression of the PI3K/AKT Signaling Pathway. Papers, record 39871069. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39871069
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Kurarinone Mitigates LPS-Induced Inflammatory Osteolysis by Inhibiting Osteoclastogenesis Through the Reduction of ROS Levels and Suppression of the PI3K/AKT Signaling Pathway.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Osteogenesis | Major topic |
| Reactive Oxygen Species | Major topic |
| Proto-Oncogene Proteins c-akt | Major topic |
| Osteolysis | Major topic |
| Osteoclasts | Major topic |
| Flavonoids | Major topic |
| Animals | |
| Lipopolysaccharides | |
| Signal Transduction | |
| Mice | |
| Phosphatidylinositol 3-Kinases | |
| RAW 264.7 Cells | |
| Inflammation |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| No. 2023A0282 | Project of Jiangxi Provincial Administration of Traditional Chinese Medicine | PubMed | ||
| No. 81860473,82360419 | National Nature Science Foundation of China | PubMed | ||
| No.8210298001 | Double-thousand Plan Program of Jiangxi Province | PubMed | ||
| No. YFYLCYJPY202202 | Clinical Cultivation Project of The First Affiliated Hospital of Nanchang University | PubMed | ||
| No. GJJ2200182 | Research Project of Jiangxi Provincial Department of Education | PubMed | ||
| No.202310504 | Research Project of Health Commission of Jiangxi Province | PubMed |
Source PubMed
References47
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12748652 | Osteoclast differentiation and activation. | Nature | 2003 | https://conductscience.org/library/papers/12748652 | PubMed |
| 2 | 38776674 | Notoginsenoside R1 treatment facilitated Nrf2 nuclear translocation to suppress ferroptosis via Keap1/Nrf2 signaling pathway to alleviated high-altitude myocardial injury. | Biomed Pharmacother | 2024 | https://conductscience.org/library/papers/38776674 | PubMed |
| 3 | 32927921 | Osteoblast-Osteoclast Communication and Bone Homeostasis. | Cells | 2020 | https://conductscience.org/library/papers/32927921 | PubMed |
| 4 | 11786679 | Growth hormone therapy in the glucocorticosteroid-dependent child: metabolic and linear growth effects. | Horm Res | 2001 | https://conductscience.org/library/papers/11786679 | PubMed |
| 5 | 26065002 | Mechanisms of Bone Resorption in Periodontitis. | J Immunol Res | 2015 | https://conductscience.org/library/papers/26065002 | PubMed |
| 6 | 28569732 | Inflammatory osteolysis: a conspiracy against bone. | J Clin Invest | 2017 | https://conductscience.org/library/papers/28569732 | PubMed |
| 7 | 35270012 | Inflammation and Bone Metabolism in Rheumatoid Arthritis: Molecular Mechanisms of Joint Destruction and Pharmacological Treatments. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35270012 | PubMed |
| 8 | 34646138 | Five-Decade Update on Chemopreventive and Other Pharmacological Potential of Kurarinone: a Natural Flavanone. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34646138 | PubMed |
| 9 | 20569521 | Flavonoids as anti-inflammatory agents. | Proc Nutr Soc | 2010 | https://conductscience.org/library/papers/20569521 | PubMed |
| 10 | 19385054 | Catalase delivery for inhibiting ROS-mediated tissue injury and tumor metastasis. | Adv Drug Deliv Rev | 2009 | https://conductscience.org/library/papers/19385054 | PubMed |
| 11 | 38671436 | PTEN: an emerging target in rheumatoid arthritis? | Cell Commun Signal | 2024 | https://conductscience.org/library/papers/38671436 | PubMed |
| 12 | 35641491 | The role of the PI3K/AKT signalling pathway in the corneal epithelium: recent updates. | Cell Death Dis | 2022 | https://conductscience.org/library/papers/35641491 | PubMed |
| 13 | 31165007 | The Anti-Inflammatory and Anti-Oxidant Mechanisms of the Keap1/Nrf2/ARE Signaling Pathway in Chronic Diseases. | Aging Dis | 2019 | https://conductscience.org/library/papers/31165007 | PubMed |
| 14 | 36235631 | Monotropein Protects against Inflammatory Bone Loss and Suppresses Osteoclast Formation and Bone Resorption by Inhibiting NFATc1 via NF-κB and Akt/GSK-3β Pathway. | Nutrients | 2022 | https://conductscience.org/library/papers/36235631 | PubMed |
| 15 | 37804813 | Kurarinone exerts anti-inflammatory effect via reducing ROS production, suppressing NLRP3 inflammasome, and protecting against LPS-induced sepsis. | Biomed Pharmacother | 2023 | https://conductscience.org/library/papers/37804813 | PubMed |
| 16 | 26998193 | ROS and ROS-Mediated Cellular Signaling. | Oxid Med Cell Longev | 2016 | https://conductscience.org/library/papers/26998193 | PubMed |
| 17 | 1664645 | Kinetics of the osteoclast cytoskeleton during the resorption cycle in vitro. | J Bone Miner Res | 1991 | https://conductscience.org/library/papers/1664645 | PubMed |
| 18 | 36835184 | Oxidative Stress and Inflammation in Osteoporosis: Molecular Mechanisms Involved and the Relationship with microRNAs. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36835184 | PubMed |
| 19 | 11450700 | Organization of cytoskeletal F-actin, G-actin, and gelsolin in the adhesion structures in cultured osteoclast. | J Bone Miner Res | 2001 | https://conductscience.org/library/papers/11450700 | PubMed |
| 20 | 21377852 | Osteogenic effects of flavonoid aglycones from an osteoprotective fraction of Drynaria fortunei--an in vitro efficacy study. | Phytomedicine | 2011 | https://conductscience.org/library/papers/21377852 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42588190 | An Inulin-Type Atractylodes Macrocephala Polysaccharide Alleviates Weightlessness-Induced Bone Loss in Association with the Nrf2/HO-1 Pathway. | Nutrients | 2026 | https://conductscience.org/library/papers/42588190 | PubMed |
| 42375095 | Isoschaftoside Inhibits Osteoclastogenesis by Suppressing the NF-κB and MAPK Pathways. | Biomol Ther (Seoul) | 2026 | https://conductscience.org/library/papers/42375095 | PubMed |
| 42307068 | Identifying Shared Key Genes and Cellular Characteristics Between Chronic Periodontitis and Aging Using Integrative Single-Cell and Mendelian Randomization Analyses. | Biomed Res Int | 2026 | https://conductscience.org/library/papers/42307068 | PubMed |
| 42291408 | Kurarinone: From chemistry to pharmacological values-A review. | Iran J Basic Med Sci | 2026 | https://conductscience.org/library/papers/42291408 | PubMed |
| 41963483 | 6-Hydroxyflavone Attenuates Inflammatory Osteolysis by Inhibiting Osteoclast Activation via the Nrf2 and Calcium Signaling Pathways. | Inflammation | 2026 | https://conductscience.org/library/papers/41963483 | PubMed |
| 41646868 | The Nrf2/HO-1 signaling pathway in arthritis: from molecular mechanisms to therapeutic potential. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/41646868 | PubMed |
| 41484074 | Inflammatory bone loss and signaling pathways in periodontitis: mechanistic insights and emerging therapeutic strategies. | Bone Res | 2026 | https://conductscience.org/library/papers/41484074 | PubMed |
| 41153240 | Association of Hemoglobin to Red Blood Cell Distribution Width Ratio and Total Bone Mineral Density in U.S. Adolescents: The NHANES 2011-2018. | Diagnostics (Basel) | 2025 | https://conductscience.org/library/papers/41153240 | PubMed |
| 40667446 | The role of oxidative balance score in Cardiovascular-Kidney-Metabolic syndrome progression and mortality: insights from NHANES 1999-2020. | Front Nutr | 2025 | https://conductscience.org/library/papers/40667446 | PubMed |
| 40309038 | The potential crosstalk genes and molecular mechanisms between systemic lupus erythematosus and periodontitis. | Front Genet | 2025 | https://conductscience.org/library/papers/40309038 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39871069
GET https://conductscience.org/api/papers/v1/39871069/references?page=2